Company Filing History:
1 out of 801 
1 out of 50 
1 out of 75 
Years Active: 2000-2024
Title: Peggy A Radel: Innovator in Patient-Specific Anti-Cancer Therapeutics
Introduction
Peggy A Radel is a distinguished inventor based in Berkeley, CA (US). She has made significant contributions to the field of cancer therapeutics, particularly in developing methods for producing patient-specific anti-cancer treatments. With a total of 5 patents to her name, her work is at the forefront of innovative medical solutions.
Latest Patents
One of Peggy's latest patents focuses on methods of producing patient-specific anti-cancer therapeutics. This patent outlines a method for preparing an antibody therapeutic that involves several steps. First, a dissociated cell sample is obtained from a solid tumor sample from a patient. Next, this sample is loaded into a microfluidic device designed with a flow region and at least one isolation region. The process includes moving at least one B cell from the dissociated cell sample into the isolation region, resulting in the isolation of B cells. Finally, the microfluidic device is used to identify B cells that produce antibodies capable of binding to cancer cells, which can be the patient's own cancer cells. This innovative approach also includes methods for treating patients, labeling or detecting cancer, and engineering T or NK cells with antibodies or fragments thereof.
Career Highlights
Throughout her career, Peggy has worked with notable companies such as PerkinElmer Corporation and Onyx Therapeutics, Inc. Her experience in these organizations has allowed her to develop and refine her expertise in the field of cancer therapeutics.
Collaborations
Peggy has collaborated with esteemed colleagues, including Kevin T Chapman and George L Fox. These partnerships have contributed to her innovative research and development efforts in the medical field.
Conclusion
Peggy A Radel is a pioneering inventor whose work in patient-specific anti-cancer therapeutics is making a significant impact in the medical community. Her innovative methods and collaborations continue to advance the fight against cancer.